Israeli startup will use PRP product to treat tennis elbow, ACL, rotator cuff, meniscus and cartilage

COLLPLANT: POSITIVE RESULTS FOR TENDINOPATHY PRODUCT (Orthopedics This Week) CollPlant website CollPlant Ltd., an Israeli regenerative medicine company, is announcing good things for its tendinopathy treatment product, VergenixSTR. The company, which is on schedule to receive CE mark approval for this product in the third quarter of 2016, uses plant-based technology. As indicated in the August 17, 2016 news release, “The prospective, open label, single-arm trial was conducted at three leading Israeli hospitals (Meir Medical Center, Assaf Harofeh Medical Center and Hadassah Hospital), and the t...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top